Skip to main content

Want a detailed portfolio tracker?

Nurix Therapeutics (NRIX) P/E (2020 - 2026)

Nurix Therapeutics (NRIX) P/E from Aug 31, 2020 to Jul 21, 2026. The TTM Nurix Therapeutics (NRIX) P/E is -6.52. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nurix Therapeutics (NRIX)

YearP/EChange
2026-6.52+10.06%
2025-5.93-4.39%
2024-6.20+79.74%
2023-3.45+23.02%
2022-2.80-73.80%
2021-10.70-67.81%
2020-33.24N/A

Comparison Nurix Therapeutics (NRIX) P/E with competitors

Nurix Therapeutics (NRIX) P/E is -6.52.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.07%
ENLVEnlivex Ltd0.07-101.15%
FGENFibroGen Inc0.24-103.68%
CHRSCoherus Biosciences Inc0.85-113.01%
FBIOFortress Biotech Inc0.95-114.55%
ORMPOramed Pharmaceuticals Inc1.50-123.04%
AGENAgenus Inc3.01-146.13%
INVAInnoviva Inc3.15-148.34%
VXRTVaxart Inc3.55-154.41%
CRMDCorMedix Inc3.63-155.61%
CVACCureVac N.V.4.45-168.14%
GLPGGalapagos NV4.86-174.47%
SRPTSarepta Therapeutics Inc4.88-174.83%
ABEOAbeona Therapeutics Inc5.39-182.57%
ABUSArbutus Biopharma Corp5.60-185.76%
ZVRAZevra Therapeutics Inc5.89-190.23%
SPROSpero Therapeutics Inc6.23-195.46%
CGENCompugen Ltd6.31-196.77%
RIGLRigel Pharmaceuticals6.87-205.33%
SLXNSilexion Therapeutics Corp7.30-211.83%
OMEROmeros Corporation9.26-241.91%
AUPHAurinia Pharmaceuticals Inc9.58-246.91%
PLXProtalix BioTherapeutics Inc10.89-266.93%
ACADAcadia Pharmaceuticals Inc11.73-279.76%
TBPHTheravance Biopharma Inc12.26-287.94%
ADMAAdma Biologics Inc12.42-290.33%
HRMYHarmony Biosciences Holdings Inc13.82-311.82%
SABSSAB Biotherapeutics Inc14.14-316.66%
NAGENiagen Bioscience Inc14.82-327.12%
INCYIncyte Corp15.82-342.51%
REGNRegeneron Pharmaceuticals Inc15.86-343.03%
PBYIPuma Biotechnology Inc17.32-365.40%
CPRXCatalyst Pharmaceuticals Inc17.44-367.29%
EXELExelixis Inc17.54-368.80%
TGTXTG Therapeutics Inc18.97-390.69%
MDXGMimedx Group Inc20.55-415.01%
XOMAXOMA Royalty Corp22.87-450.61%
ARGXArgen X SE24.30-472.42%
CTMXCytomX Therapeutics Inc24.82-480.44%
XOMAOXOMA Royalty Corp25.34-488.47%
HALOHalozyme Therapeutics Inc25.62-492.74%
XOMAPXOMA Royalty Corp25.67-493.45%
VRTXVertex Pharmaceuticals Inc27.99-529.08%
RPRXRoyalty Pharma plc - Class A28.69-539.70%
SLNOSoleno Therapeutics Inc29.02-544.73%
ASNDAscendis Pharma A/S30.09-561.13%
LGNDLigand Pharmaceuticals Inc - Class B37.91-681.09%
APLSApellis Pharmaceuticals Inc39.02-698.09%
BMRNBiomarin Pharmaceutical Inc42.21-747.00%
KRYSKrystal Biotech Inc45.34-795.00%
ONCBeiGene Ltd69.54-1165.87%
PHARPharming Group N.V.75.03-1249.94%
TECHBio-Techne Corp101.96-1662.75%
VCELVericel Corp109.92-1784.80%
ALNYAlnylam Pharmaceuticals Inc117.96-1908.09%
GMABGenmab140.29-2250.29%
TLXTelix Pharmaceuticals Ltd162.15-2585.37%
CORTCorcept Therapeutics Inc212.86-3362.54%